Skip to main content
Category

Uncategorized

Artgen logo 04-e1455902609177

Artgen Inc.

By Uncategorized

 

Artgen logo 04-e1455902609177

Artgen, Inc. is a biotechnology company developing breakthrough treatments for vascular diseases. The company has a pipeline of preclinical therapeutic candidates with the first product (Art101) developed for treatment of Peripheral Arterial Disease (PAD).

Founders: Maxim Tvishor, Irena Tsyrlova

BHI Lead Contact: Albine Martin

Investment: Maryland Industral Partnerships (MIPS), Human Stem Cells Institute (Seed Investment)

*BHI Cofounded Company

 

 

 

 

MIMETAS US

By Uncategorized

www.mimetas.com

Mimetas is developing and marketing Organ-on-a-Chip solutions for the pharmaceutical industry

Founder: Jos Joore / Paul Vulto

BHI Lead Contact: Anthony Saleh

Source: Netherlands / University of Leiden

 

 

 

BeneVir

By Uncategorized

www.benevir.com

BeneVir is developing a therapeutic platform that has the potential to cure cancer in patients with advanced tumors

Founder: Matt Mulvey

Source: Montgomery County BioTech Company

 

 

 

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.